388 related articles for article (PubMed ID: 24548425)
21. Evaluation of the efficacy of the subcutaneous low recombinant feline interferon-omega administration protocol for feline chronic gingivitis-stomatitis in feline calicivirus-positive cats.
Matsumoto H; Teshima T; Iizuka Y; Sakusabe A; Takahashi D; Amimoto A; Koyama H
Res Vet Sci; 2018 Dec; 121():53-58. PubMed ID: 30359811
[TBL] [Abstract][Full Text] [Related]
22. Complementary effect of oral administration of Lactobacillus paracasei K71 on canine atopic dermatitis.
Ohshima-Terada Y; Higuchi Y; Kumagai T; Hagihara A; Nagata M
Vet Dermatol; 2015 Oct; 26(5):350-3, e74-5. PubMed ID: 26123498
[TBL] [Abstract][Full Text] [Related]
23. Cyclosporin A Treatment in Intrinsic Canine Atopic Dermatitis (Atopic-like Dermatitis): Open Trial Study.
Fujimura M; Nakatsuji Y; Ishimaru H
Pol J Vet Sci; 2016 Sep; 19(3):567-572. PubMed ID: 27760033
[TBL] [Abstract][Full Text] [Related]
24. Tepoxalin reduces pruritus and modified CADESI-01 scores in dogs with atopic dermatitis: a prospective, randomized, double-blinded, placebo-controlled, cross-over study.
Horvath-Ungerboeck C; Thoday KL; Shaw DJ; van den Broek AH
Vet Dermatol; 2009 Aug; 20(4):233-42. PubMed ID: 19552701
[TBL] [Abstract][Full Text] [Related]
25. The efficacy of cetirizine hydrochloride on the pruritus of cats with atopic dermatitis: a randomized, double-blind, placebo-controlled, crossover study.
Wildermuth K; Zabel S; Rosychuk RA
Vet Dermatol; 2013 Dec; 24(6):576-81, e137-8. PubMed ID: 24112588
[TBL] [Abstract][Full Text] [Related]
26. The efficacy of a commercial shampoo and whirlpooling in the treatment of canine pruritus - a double-blinded, randomized, placebo-controlled study.
Löflath A; von Voigts-Rhetz A; Jaeger K; Schmid M; Kuechenhoff H; Mueller RS
Vet Dermatol; 2007 Dec; 18(6):427-31. PubMed ID: 17991160
[TBL] [Abstract][Full Text] [Related]
27. The efficacy of commercially available veterinary diets recommended for dogs with atopic dermatitis.
Glos K; Linek M; Loewenstein C; Mayer U; Mueller RS
Vet Dermatol; 2008 Oct; 19(5):280-7. PubMed ID: 18699815
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of an essential fatty acid-enriched diet in managing canine atopic dermatitis: a randomized, single-blinded, cross-over study.
Bensignor E; Morgan DM; Nuttall T
Vet Dermatol; 2008 Jun; 19(3):156-62. PubMed ID: 18477332
[TBL] [Abstract][Full Text] [Related]
29. Clinical efficacy of low-level laser therapy on localized canine atopic dermatitis severity score and localized pruritic visual analog score in pedal pruritus due to canine atopic dermatitis.
Stich AN; Rosenkrantz WS; Griffin CE
Vet Dermatol; 2014 Oct; 25(5):464-e74. PubMed ID: 24909192
[TBL] [Abstract][Full Text] [Related]
30. A comparative study of subcutaneous, intralymphatic and sublingual immunotherapy for the long-term control of dogs with nonseasonal atopic dermatitis.
Fischer NM; Rostaher A; Favrot C
Vet Dermatol; 2020 Oct; 31(5):365-e96. PubMed ID: 32537789
[TBL] [Abstract][Full Text] [Related]
31. A blinded, randomized, placebo-controlled, dose determination trial of lokivetmab (ZTS-00103289), a caninized, anti-canine IL-31 monoclonal antibody in client owned dogs with atopic dermatitis.
Michels GM; Ramsey DS; Walsh KF; Martinon OM; Mahabir SP; Hoevers JD; Walters RR; Dunham SA
Vet Dermatol; 2016 Dec; 27(6):478-e129. PubMed ID: 27647569
[TBL] [Abstract][Full Text] [Related]
32. The influence of topical unsaturated fatty acids and essential oils on normal and atopic dogs.
Tretter S; Mueller RS
J Am Anim Hosp Assoc; 2011; 47(4):236-40. PubMed ID: 21673338
[TBL] [Abstract][Full Text] [Related]
33. The effect of nematode administration on canine atopic dermatitis.
Mueller RS; Specht L; Helmer M; Epe C; Wolken S; Denk D; Majzoub M; Sauter-Luis C
Vet Parasitol; 2011 Sep; 181(2-4):203-9. PubMed ID: 21621922
[TBL] [Abstract][Full Text] [Related]
34. Management of canine atopic dermatitis using the plant extract PYM00217: a randomized, double-blind, placebo-controlled clinical study.
Ferguson EA; Littlewood JD; Carlotti DN; Grover R; Nuttall T
Vet Dermatol; 2006 Aug; 17(4):236-43. PubMed ID: 16827666
[TBL] [Abstract][Full Text] [Related]
35. Masitinib decreases signs of canine atopic dermatitis: a multicentre, randomized, double-blind, placebo-controlled phase 3 trial.
Cadot P; Hensel P; Bensignor E; Hadjaje C; Marignac G; Beco L; Fontaine J; Jamet JF; Georgescu G; Campbell K; Cannon A; Osborn SC; Messinger L; Gogny-Goubert M; Dubreuil P; Moussy A; Hermine O
Vet Dermatol; 2011 Dec; 22(6):554-64. PubMed ID: 21668810
[TBL] [Abstract][Full Text] [Related]
36. Correlation between clinical efficacy on pruritus and serum interleukin-31 levels in dogs with atopic dermatitis treated with lokivetmab.
Calesso JR; Marques VS; de Carvalho OV; Costa-Val AP
Pol J Vet Sci; 2023 Jun; 26(2):231-238. PubMed ID: 37389418
[TBL] [Abstract][Full Text] [Related]
37. Cyclosporine decreases skin lesions and pruritus in dogs with atopic dermatitis: a blinded randomized prednisolone-controlled trial.
Olivry T; Rivierre C; Jackson HA; Murphy KM; Davidson G; Sousa CA
Vet Dermatol; 2002 Apr; 13(2):77-87. PubMed ID: 11972891
[TBL] [Abstract][Full Text] [Related]
38. Clinical effects of the recombinant feline interferon-omega on experimental parvovirus infection in beagle dogs.
Ishiwata K; Minagawa T; Kajimoto T
J Vet Med Sci; 1998 Aug; 60(8):911-7. PubMed ID: 9764403
[TBL] [Abstract][Full Text] [Related]
39. Barazone decreases skin lesions and pruritus and increases quality of life in dogs with atopic dermatitis: a randomized, blinded, placebo-controlled trial.
Ahlstrom LA; Mason KV; Mills PC
J Vet Pharmacol Ther; 2010 Dec; 33(6):573-82. PubMed ID: 21062310
[TBL] [Abstract][Full Text] [Related]
40. Clinical trial evaluating the efficacy and safety of cyclosporine in dogs with atopic dermatitis.
Steffan J; Parks C; Seewald W;
J Am Vet Med Assoc; 2005 Jun; 226(11):1855-63. PubMed ID: 15934253
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
